Munich, 13 March 2020.
The leading virologist and Entourage advisor Prof. Dr. Günther Schönrich gives an assessment of the current situation of the coronavirus in Germany and Europe.
In an interview with Deutsche Welle, leading virologist and Entourage advisor Prof. Dr Günther Schönrich gives his assessment of the coronavirus situation in Germany and Europe.
In his view, the epidemic has not yet reached its peak. It will gain momentum in the coming weeks. He therefore considers it necessary to take the appropriate measures to end the spread of the virus. In this way, time could be gained to develop a drug that helps to stop the spread of the virus in the human organism.
In the coming weeks, Entourage will keep you informed about the latest developments on the topic of coronavirus by Prof. Schönrich.
Short profile Prof. Dr. Günther Schönrich.
Prof. Dr. med. Günther Schönrich studied medicine and philosophy at the Albert Ludwigs University in Freiburg and received his doctorate in medicine in 1985, specializing in cardiology. He completed his postdoctoral studies at the Institute of Immunology and Genetics of the German Cancer Research Center in Heidelberg. Mr. Schönrich has in-depth knowledge in the fields of microbiology, virology, infectious disease epidemiology, and immunology. Since 2006, Mr. Schönrich has been Deputy Director of the Institute of Virology (CCM) at Charité-Universitätsmedizin Berlin.
Short Profile Entourage.
Entourage is a management and HR consultancy with a focus on pharmaceuticals, medical technology and health care. With the placement of permanent scientific employees and consultants, the Munich and Basel-based company wins experts for the leading life science companies in the DACH region. With Project Consultants, Entourage realises projects for clients through highly qualified temporary staffing and work contracts. With the Entourage Task Force (ETF), Entourage bundles selected interim managers and management consultants into a high-calibre consulting unit that implements pharmaceutical and medical technology solution scenarios in consulting projects on an interdisciplinary basis.